KDR and melanoma: Interestingly, analysis of KDR alterations as a general prognostic marker in melanoma using The Cancer Genome Atlas (TCGA) data through the C-Bio portal [39] did not show a statistically significant correlation to overall or disease-free survival, suggesting KDR becomes an important marker only in the setting of BRAF-directed MAPK pathway therapy.